Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleCemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- La Jolla
- Age
- 18 years and over
- People
- 43
- Run by
- University of California, San Diego
See details and how to joinNCT06790602 - Phase 1Taking peopleStudy of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Where
- Baltimore, Boston, Cincinnati, Dallas, Durham, Fairfax, Houston, Huntersville, Nashville, New Haven, New York, Sacramento, San Antonio, Sarasota, Tampa
- Age
- 18 years and over
- People
- 604
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06040541 - No phaseTaking peopleIntravital Microscopy in Human Solid Tumors
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 85
- Run by
- Mayo Clinic
See details and how to joinNCT03823144 - Phase 1Taking peopleBBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Where
- Boston, Dallas, Houston, Los Angeles, Nashville, New Haven, New York, Peoria, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Tampa
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06917079 - No phaseTaking peopleMyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 30
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07619391 - Early phase 1Taking peopleProspective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
- Where
- Boston
- Age
- 18 years and over
- People
- 5,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06122896 - Phase 1/2Taking peopleA Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
- Where
- Houston
- Age
- 18 years and over
- People
- 78
- Run by
- Crossignal Therapeutics, Inc.
See details and how to joinNCT06598007 - Phase 2Taking peopleEndoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms
- Where
- Columbus
- Age
- 18 years and over
- People
- 35
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07529483 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- Where
- Baltimore, Fairfax, San Antonio, West Valley City
- Age
- 18 years and over
- People
- 252 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07223047 - Phase 1Not yet taking people in United States64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer
- Where
- Duarte
- Age
- 18 years and over
- People
- 15
- Run by
- City of Hope Medical Center
See details and how to joinNCT07608627 - No phaseNot yet taking people in United StatesThe Canopy Cancer Collective Clinical Registry Protocol
- Where
- Baltimore, Buffalo, Cleveland, Dallas, Lake Success, New York, San Antonio, San Diego, Seattle, Tampa
- Age
- 18 years and over
- People
- 100,000
- Run by
- Canopy Cancer Collective, LLC
See details and how to joinNCT07605702 - Phase 3Taking peopleStudying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Where
- Aberdeen, Aitkin, Ames, Anaconda, Anchorage, Arroyo Grande, Ashland, Atlanta, Auburn, Baltimore, Bardstown, Baton Rouge, Battle Creek, Baxter, Bellingham, Bend, Berkeley, Billings, Bloomington, Boise, Boone, Bozeman, Brainerd, Burbank, Burlingame, Cameron Park, Canton, Cape Girardeau, Carbondale, Carmichael, Carterville, Carthage, Castro Valley, Cedar Rapids, Centerville, Centralia, Chadds Ford, Cheyenne, Cincinnati, Clackamas, Clinton, Clive, Cody, Coeur d'Alene, Collierville, Colorado Springs, Columbus, Coos Bay, Corbin, Creston, Crosslake, Danville, Davis, Dayton, Decatur, Deer River, Des Moines, Detroit Lakes, Dixon, Duluth, Durango, Edmonds, Effingham, Elk Grove, Elkton, Ely, Escanaba, Eureka, Everett, Fairfax, Fargo, Farmington, Fayetteville, Fort Dodge, Fosston, Franklin, Fremont, Fruitland, Galesburg, Goldsboro, Grand Island, Grand Rapids, Great Falls, Green Bay, Greenville, Grenada, Havre, Hayward, Helena, Hibbing, Hood River, International Falls, Issaquah, Jacksonville, Jamestown, Jefferson, Johns Creek, Jonesboro, Kalamazoo, Kalispell, Kearney, Kennewick, Kewanee, Lacey, La Crosse, Lakeland, Lakewood, Lewes, Lexington, London, Longmont, Longview, Macomb, Marshalltown, Mattoon, Memphis, Merced, Meridian, Millville, Missoula, Modesto, Moose Lake, Mountain View, Mount Sterling, Mount Vernon, Muskegon, Nampa, Napa, New Albany, Newark, Newberg, Niles, Normal, Norton Shores, Novato, Oconto Falls, O'Fallon, Omaha, Oregon City, Ottawa, Oxford, Palo Alto, Park Rapids, Pekin, Peoria, Pequot Lakes, Peru, Phoenix, Pinehurst, Pine River, Portland, Post Falls, Princeton, Pueblo, Randallstown, Rapid City, Redmond, Reed City, Rehoboth Beach, Rocklin, Rogers, Roseville, Sacramento, Sainte Genevieve, Saint Joseph, Sandpoint, Sandstone, San Francisco, San Luis Obispo, San Mateo, Santa Barbara, Santa Cruz, Santa Maria, Santa Rosa, Seattle, Sedro-Woolley, Sheboygan, Silverdale, Southhaven, Spokane, Spooner, Springdale, Springfield, Stamford, Staples, St Louis, Stockton, Sturgeon Bay, Sullivan, Sunnyvale, Sunset Hills, Superior, Traverse City, Troy, Twin Falls, Urbana, Vallejo, Vancouver, Virginia, Walla Walla, Washington, West Chester, West Des Moines, Westminster, Wilmington, Woodland, Wyoming
- Age
- 18 years and over
- People
- 94
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT06998940 - Phase 1/2Taking peopleDose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
- Where
- Fairfax, Houston, Huntersville, Nashville, Oklahoma City, Webster
- Age
- 18 years and over
- People
- 40
- Run by
- Phanes Therapeutics
See details and how to joinNCT05431270 - Phase 1/2Taking peopleONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- St Louis
- Age
- 18 years and over
- People
- 61
- Run by
- Washington University School of Medicine
See details and how to joinNCT06904378 - Phase 1/2Taking peopleStudy of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Atlanta, Austin, Baltimore, Baton Rouge, Boston, Chattanooga, Cincinnati, Dallas, Fairfax, Houston, Maumee, Nashville, New York, Orange, Salt Lake City, San Antonio, Santa Monica, Seattle, Tampa
- Age
- 18 years and over
- People
- 754
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT05379985 - No phaseNot yet taking people in United StatesBarriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
- Where
- Houston
- Age
- 18 years and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07591480 - Phase 1/2Taking peopleNano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 100
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04789486 - Phase 1Not yet taking people in United StatesMT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 38
- Run by
- Marker Therapeutics, Inc.
See details and how to joinNCT06549751 - Phase 1Taking peopleBrodalumab in the Treatment of Immune-Related Adverse Events
- Where
- New York
- Age
- 18 years and over
- People
- 11
- Run by
- Brian Henick, MD
See details and how to joinNCT06673329 - No phaseTaking peopleNutrition Intervention for Pancreatic Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 18
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT07554560 - No phaseTaking peoplePancreatic Cancer Genetics
- Where
- New York
- Age
- 18 years to 85 years
- People
- 100
- Run by
- Columbia University
See details and how to joinNCT01102569 - No phaseTaking peopleDetermining Individualized Cancer Therapy in Pancreatic Cancer
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 1,000
- Run by
- Medical College of Wisconsin
See details and how to joinNCT05914987 - No phaseTaking peopleMolecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 40
- Run by
- Medical College of Wisconsin
See details and how to joinNCT06228599 - Phase 2Taking peopleNC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer
- Where
- Baltimore
- Age
- 18 years and over
- People
- 20
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06941857 - Phase 2Taking peopleAxelopran for Advanced Cancer in Patients Receiving Opioids
- Where
- Saint Louis Park, Saint Paul
- Age
- 18 years and over
- People
- 34
- Run by
- HealthPartners Institute
See details and how to joinNCT07354919